Biotechnology
LumiraDx Receives SARS-CoV-2 Antigen Test Authorization in Japan and Brazil; Italy Recommends Expansion of Microfluidic Antigen Testing
LONDON, Jan. 21, 2021 /PRNewswire/ -- LumiraDx, the next-generation point-of-care diagnostic testing company, announced today multinational approvals of its SARS-CoV-2 Antigen Test. With approvals inJapan and Brazil, the fast, accurate LumiraDx SARS-CoV-2 Antigen Test is now available to patie...
2021-01-21 16:00
1853
Northway Biotech Opens New Biopharmaceutical Manufacturing Facility in Greater Boston Area
WALTHAM, Mass., Jan. 21, 2021 /PRNewswire/ -- Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art, cGMP manufacturing site inEurope, announced at the virtual grand opening ceremony o...
2021-01-21 12:35
1406
Innodem Neurosciences Receives 6 Million US Dollars of Financing From Morningside Group
MONTREAL, Jan. 20, 2021 /PRNewswire/ -- Innodem Neurosciences, a Montreal-based company, has closed a Series A financing round led byMorningside Ventures to support the development and commercialization of its proprietary, patented, digital biomarking technology of neurodegenerative diseases such...
2021-01-20 12:00
2418
CytoSorbents Announces Approval of CytoSorb® in Korea in Collaboration with Partner Fresenius Medical Care
CytoSorb now commercially available in Korea – one of the leading economies in Asia - to treat cytokine storm and other illnesses in critically-ill and cardiac surgery patients MONMOUTH JUNCTION, N.J., Jan. 19, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunot...
2021-01-19 20:08
6090
InDevR Launches VaxArray Measles and Rubella Kit for Improved Vaccine Antigen Characterization
BOULDER, Colorado, Jan. 19, 2021 /PRNewswire/ -- InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial availability of its VaxArray® Measles and Rubella (MR) antigen qu...
2021-01-19 16:00
1280
Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership for Next-Generation Ophthalmic Gene Therapy
WUHAN, China and NEWARK, DE., Jan. 19, 2021 /PRNewswire/ -- Neurophth Therapeutics, Inc., a subsidiary of Wuhan Neurophth Biotechnology Ltd. gene therapy company (hereafter Neurophth), and AAVnerGene Inc., a specializing AAV technology company, today announced a strategic partnership to provide ...
2021-01-19 14:05
1471
Innovent Announces an Out-license Agreement with PT Etana Biotechnologies Indonesia to Launch BYVASDA® (Bevacizumab Biosimilar) in Indonesia
SAN FRANCISCO and SUZHOU, China, Jan. 19, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...
2021-01-19 08:00
6964
Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy
SUZHOU, China, Jan. 18, 2021 /PRNewswire/ -- Cure Genetics announced a collaboration with Boehringer Ingelheim to develop novel Adeno-Associated Virus (AAV) vectorsleveraging Cure Genetics' proprietary VELPTM platform to develop next-generation gene therapies. This new collaboration combines Boeh...
2021-01-18 22:00
2024
Hanmi Pharmaceutical expects U.S. FDA approval for 2 new drugs
* Rolontis and Oraxol BLA/NDA approval from U.S. FDA is expected within this year * LAPSTriple Agonist, an innovative triple-acting new drug for NASH treatment, indication expansion * Efpeglenatide met the primary endpoint for global Phase 3 * Striving for developing rare diseases such as...
2021-01-18 22:00
2408
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
BEDMINSTER, N.J. and SINGAPORE, Jan. 18, 2021 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced that the European Medicines Agency (EMA) has granted PRior...
2021-01-18 19:00
1792
Everest Medicines Announces Amended Agreement with Spero Therapeutics
SHANGHAI, Jan. 18, 2021 /PRNewswire/ -- Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients inGreater China and other parts ofAsia, today announced that under an amen...
2021-01-18 18:05
6259
Senhwa Biosciences Presents Positive Cholangiocarcinoma Data
TAIPEI and SAN DIEGO, Jan. 15, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announces that promising clinical data from their global phase...
2021-01-15 22:00
2802
United Immunity and Xyphos, an Astellas Company, to Collaborate on Next Generation Nano-Immunotherapies for Cancer Treatment
TOKYO, Jan. 15, 2021 /PRNewswire/ -- United Immunity, Co., Ltd. (CEO, Naozumi Harada, Ph.D. Mie,Japan), a drug discovery biotech specializing in nanoparticle-based cancer immunotherapies (nano-immunotherapies), has entered into a joint research agreement as ofDecember 2020 with Xyphos Biosciences...
2021-01-15 10:00
3613
Huami to Host 2021 Strategy and Outlook Investor Fireside Chat with CEO Wang Huang on January 22
BEIJING, Jan. 14, 2021 /PRNewswire/ -- Huami Corp. (NYSE: HMI) today announced that it will hold a Fireside Chat conference call for investors on Friday,22 January 2021. The company will discuss its 2021 strategies for consumer and industrial health technologies, including its product plans annou...
2021-01-14 19:00
10516
Samsung Biologics Shares 'Vision' for Next Decade at the 39th Annual JP Morgan Healthcare Conference
INCHEON, South Korea, Jan. 13, 2021 /PRNewswire/ -- Samsung Biologics (207940.KS) set forth its dynamic growth plan for the next decade at the 2021 Annual JP Morgan Healthcare Conference.John Rim, newly appointed President and CEO, unveiled a multidimensional business plan for the company to furt...
2021-01-13 23:17
7491
GenScript Submits Application with FDA for Use of cPass™ SARS-CoV-2 Neutralization Antibody Test in Convalescent Plasma Screening
PISCATAWAY, N.J., Jan. 13, 2021 /PRNewswire/ -- GenScript USA Inc., the world's leading research reagent provider, announced today that it has submitted an application to the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) for use of the cPass™ SARS-CoV-2 N...
2021-01-13 20:30
5370
VesCir poised to revolutionize skincare industry at CES 2021 with AI-driven 'iCi' skincare system
TAIPEI, Jan. 12, 2021 /PRNewswire/ -- Taiwanese biotech startup, VesCir, inspired by Nasa's Skin.B project, will have a launch of its ownthis year at CES 2021, where it will showcase its medical grade portable dynamic skincare system; a first on the market. The future of skincare now; "Dynamic...
2021-01-13 09:33
1727
CES 2021 Taiwanese biotech startup mProbe CADx develops AI health analysis platform
TAIPEI, Jan. 12, 2021 /PRNewswire/ -- mProbe Taiwan is a subsidiary biotechnology company of mProbe Inc, committed to promoting human health and wellness by transforming the field of precision health and precision medicine. With multi-omics as the critical evidence, mProbe has endeavored to inter...
2021-01-13 02:49
1594
Kira Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass. and SUZHOU, China, Jan. 12, 2021 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced thatFrederick Beddingfield, Chief Executive Officer of Kira Pharm...
2021-01-12 22:57
1914
Caprion-HistoGeneX Expands its Histological Biomarker Franchise by Joining Forces with Mosaic Laboratories
MONTREAL, Jan. 12, 2021 /PRNewswire/ -- Caprion-HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners ("Arsenal"), announced today the acquisition of Mosaic Laboratories LLC ("Mosaic"), aCalifornia-based company offering histology and immu...
2021-01-12 21:20
2056
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
5608
